CCR9 inhibitors and methods of use thereof

CCR9 inhibitors and methods of use thereof

C:\NHPonblI)CC\ R'j I2 _ .gI) OC.21AIv Il2 The invention relates to compounds represented by Structural Formula 1, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HARRIMAN, GERALDINE C. B, SHI, ZHAN, FLEMING, PAUL, CHEN, SHAOWU
Format: Patent
Sprache:eng
Schlagworte:
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:C:\NHPonblI)CC\ R'j I2 _ .gI) OC.21AIv Il2 The invention relates to compounds represented by Structural Formula 1, which can bind to CCR9 receptors and block the binding of a ligand (e.g., TECK) to the receptors. The invention also relates to a method of inhibiting a function of CCR9, and to the use coiIpounds represented by Structural Formula I in research, therapeutic, prophylactic and diagnostic methods.